Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Sui

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 28, 2024
Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy ResponseJun Xue, Shuai Yang, Si-Si Zhang, et al.
Immunity & Ageing : I & A|September 27, 2022
The reference ranges and characteristics of lymphocyte parameters and the correlation between lymphocyte parameters and routine health indicators in adults from ChinaWei Liu, Jie Xu, Qiyao Pu, et al.
Theranostics|May 7, 2020
Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinomaJing Tang, Cheng-Jun Sui, Dong-Fang Wang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 31, 2018
Liver resection is justified for multinodular hepatocellular carcinoma in selected patients with cirrhosis: A multicenter analysis of 1,066 patientsZhen-Li Li, Jiong-Jie Yu, Jun-Wu Guo, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 28, 2024
Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy ResponseJun Xue, Shuai Yang, Si-Si Zhang, et al.
Immunity & Ageing : I & A|September 27, 2022
The reference ranges and characteristics of lymphocyte parameters and the correlation between lymphocyte parameters and routine health indicators in adults from ChinaWei Liu, Jie Xu, Qiyao Pu, et al.
Theranostics|May 7, 2020
Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinomaJing Tang, Cheng-Jun Sui, Dong-Fang Wang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 31, 2018
Liver resection is justified for multinodular hepatocellular carcinoma in selected patients with cirrhosis: A multicenter analysis of 1,066 patientsZhen-Li Li, Jiong-Jie Yu, Jun-Wu Guo, et al.
Pageof 9